A panel of federal health experts dealt a surprising setback to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug's side effects outweigh its ability to help patients lose weight.
Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, announced the introduction of high-performance, AFFINILUTE MIP (Molecularly Imprinted Polymers) columns for analytical sample preparation.
Prior Scientific has just introduced the ZDeck Quick Adjust Platform System for Olympus BX51WI and BX61WI microscopes. The ZDeck Quick Adjust Platform System increases productivity by allowing the user to image multiple areas of interest with unsurpassed speed and precision.
Researchers have reported that Rituximab, a drug that is FDA approved to treat B cell lymphoma and rheumatoid arthritis, can also treat severe vasculitis as well as the current standard therapy.
Researchers have used a newly discovered class of biomarkers to investigate the possibility that the shape of brain protein deposits is different in people with Alzheimer's who have the highest-risk gene type than in those with the neutral risk gene.
Merck KGaA, a global pharmaceutical and chemical company, announced the successful completion of its acquisition of Millipore Corporation for $7 billion.
Drug maker Novartis AG reported a second-quarter increase in net profit of 19%, as sales in its pharmaceuticals business offset health care cost-cutting efforts by some European governments.
Keryx Biopharmaceuticals Inc. said that its experimental cancer drug perifosine received orphan drug status as a treatment for neuroblastoma, a cancer that affects the nervous system and mostly strikes young children.
An experimental diet pill helped about half the people who tried it lose some weight and keep it off a year later, without the heart problems that some earlier drugs caused, a study found.
Novartis will pay up to $152.5 million to potentially thousands of women after a jury found it discriminated against them by paying them less than men, the pharmaceutical company and plaintiffs' lawyers announced Wednesday after a deal was struck.
GlaxoSmithKline's drug Avandia should stay on the market, federal health experts voted, but the controversial diabetes pill should be subject to new restrictions due to risky heart side effects.
FLEXYTE protease assays harness the power and potential of fluorescence lifetime technology for robust, efficient and economical screening of proteases.
DRAQ7 from Biostatus Ltd. is a live cell-impermeant far-red fluorescing DNA dye with the same spectral properties that already made DRAQ5 a reagent of choice.
The search for new drug compounds is probably worse than looking for a needle in a haystack because scientists are limited in the size of the haystacks they can rummage through—time and money make it virtually impossible to screen or search through super-large libraries of potential compounds.
With its wide linear range, combined static and dynamic combustion technology and horizontal furnace design allowing for removal of residues between runs, the Exeter Analytical CE-440 CHN/O/S elemental analyzer is uniquely capable of accurately analyzing the widest range of sample types - quickly, easily and reliably.